Darren Wildman

Full time AIM investor and car fanatic

[Darren Wildman @WildmanDarren]

#Dest - This is why people are getting excited about Destiny Pharma. Game changing product in a $2 billion market in the US alone!
Destiny Pharma PLC - Publication of new microbiological data for XF-73 #DEST @DestinyPharma https://t.co/qEDnmh0wwN #voxmarkets undefined

[Darren Wildman @WildmanDarren]

#DEST Stopping Hospital acquired infections is a very exciting market ($2 billion). A market that could be monopolised by Destiny Pharma in very short order. Very exciting times! Tiny MC currently so amazing scope for the SP…

[Proactive @proactive_x]

$DEST Destiny Pharma financed and partnered; broker upbeat https://t.co/UyFQVN4eeG @destinypharma $DTTYF #DEST #DTTYF

[BiotechTechNow @MedTechNow_]

more #funding #news

~@HemogenyxPharma announces strategic #Investment from @PrevailPartners

~#Avasa raises $1.55M in #oversubscribed #funding round with innovative #implantable devices

~@RadiactionMed raises $12.6M in #SeriesC2 #funding

[Darren Wildman @WildmanDarren]

#HEMO receives a significant investment at 240% premium to SP. Plus patent recently filed for a whole new virus treatment platform: Hemogenyx Pharmaceuticals shares soar on Prevail tie-up | LSE:HEMO https://t.co/cFplY3BH03

[Darren Wildman @WildmanDarren]

#HEMO always encouraging to see a small cap Pharma getting an investment 240% above the current SP. Someone believes!

[Vox Markets @VOXmarkets]

"We are very confident in Prevail InfoWorks' ability to coordinate our Phase I clinical trial in relapsed/refractory AML."

@HemogenyxPharma #HEMO - Strategic Investment from Prevail Partners

🔗Detail here: https://t.co/Z2ElalRTr1

#AIM

[Share_Talk ™ @Share_Talk]

@avacta Statement regarding market speculation #AVCT has a strong cash balance of £27 million on its balance sheet as at 31 May (unaudited) and anticipates strong news flow in the coming months from across the Group. No fundraising is imminent.
https://t.co/66HLjU34c5

[Darren Wildman @WildmanDarren]

#hemo interesting article on FDA delays in these emerging cell therapies. Seemingly staffing problems at the FDA causing issues, rather than the drug development being the primary issue for delays and FDA approval holds…

[Shaun @shncoe]

Maybe this was already out of #hemo hands before they even submitted the IND #savinglives #AML #cancer #cure #investing #stockmarketnews worth a read to reach your own conclusions

https://t.co/TT2Xlo3D97

[Avacta @avacta]

In this video presentation Avacta CEO Alastair Smith provides more information on our acquisition of Coris Bioconcept and the Group's diagnostics strategy. https://t.co/OtAkTEWACV #AVCT

[Darren Wildman @WildmanDarren]

#DEST No change in the fundamentals to warrant the drop. Just the current market response to any Pharma news flow. Hold and wait for the next deal. They’re cashed up and in a great space, ready to go with a treatment for a growing (global) hospital acquired infection crisis!!

[Justin Waite @SharePickers]

Yesterday Destiny Pharma's CEO stood down for personal reasons. Some holders panicked & sold, the sp dipped.

New interim CEO appointed with more experience & 3 Directors bought shares yesterday incl new CEO.

It was probably an opportunity #DEST
https://t.co/F6tqtPeZGk

[Darren Wildman @WildmanDarren]

@BigBiteNow I would wait to see the number of scripts written look anything like a success before I made that assumption.

[Darren Wildman @WildmanDarren]

#STX burning shed loads of cash and now moving from wanting just previous intravenous patients to targeting mass market iron replacement at a significantly higher price point to competitors. Tread very carefully.

[BBN @BigBiteNow]

1/6
You leave your desk for an hour or so and look what happens!

Still getting my head around what this AOP #STX conversion truly means but the first thing that springs out is this statement from AOP.

[Darren Wildman @WildmanDarren]

#DEST correction, was a heavy night last night. My apologies #HEMO hopefully 36p one day 👍

[Darren Wildman @WildmanDarren]

#HEMO Correction now 36p on the breakout, after this morning’s news…

[Darren Wildman @WildmanDarren]

#DEST More positive news on new treatments for Covid and influenza. This new nasal spray candidate from Destiny not even considered in the 3 broker c£2.80 target price for the stock! Current SP 33p after a recent fund raise at 35p, bargain…

[Hemogenyx Pharmaceuticals PLC @HemogenyxPharma]

4. Successfully set up and qualified GMP manufacturing and analytical testing of cell therapies and implemented Quality System in a new purpose-built R&D/manufacturing facility.

[Hemogenyx Pharmaceuticals PLC @HemogenyxPharma]

2. CBR platform extended into treatment of multiple viral infections beyond COVID-19 using single CBR-based therapeutic.
3. Initiated IND-enabling activities for CDX bi-specific antibody for treatment of R/R AML.

[Darren Wildman @WildmanDarren]

# HEMO - one for the weekend research list. Raised £4m recently so got cash, lots of news flow coming around Car-T and partnership conversations happening on other assets.

[Hemogenyx Pharmaceuticals PLC @HemogenyxPharma]

We announce the publication of our 2022 annual report with operational update:
https://t.co/LYDswSkPlK
Highlights:
1. Nearing completion of IND application to enter phase I clinical trials for HEMO-CAR-T for the treatment of R/R AML.

[Darren Wildman @WildmanDarren]

#IOG up to 4 week delay to drill due to safety issues. Could be a great trade?

[Goldman V*king Sachs⚔️ @Borg74]

News!! I am not happy to see this fall because a few people I know are in #IOG but this "news will blow the chart out of the water" is a cliché I don't subscribe too.

6.52 was target as per my tweet. That was technical based. I have not read the RNS.

[Darren Wildman @WildmanDarren]

@Borg74 #IOG broken 6.00 strongly. More to come…

[Darren Wildman @WildmanDarren]

5.34. Now Bingo

[Goldman V*king Sachs⚔️ @Borg74]

#IOG 5.26 watch 5.27 yes even 2 decimal places can make all the difference. If 5.27 clears then upto next level.

[Darren Wildman @WildmanDarren]

@Borg74 #IOG Looking strong at 5.65 with news to grow into

[Darren Wildman @WildmanDarren]

Very healthy bounce into news due 👍

[Share_Talk ™ @Share_Talk]

Market Summary > @IOG_plc
LON #IOG
6.20 GBX+1.72 (38.37%)⤴️past 5 days
14 Apr, 10:26 BST • Disclaimer
@Justsharesonaim graph is for illustration purposes